|
Volumn 3, Issue 4, 2006, Pages 191-194
|
Advances in the diagnosis, treatment, and understanding of Parkinson's disease and parkinsonism
|
Author keywords
Botulinum toxin; Deep brain stimulation; Drug induced parkinsonism; Estrogen replacement therapy; Parkinson's disease; Substantia nigra
|
Indexed keywords
ARIPIPRAZOLE;
ATYPICAL ANTIPSYCHOTIC AGENT;
BOTULINUM TOXIN;
CONJUGATED ESTROGEN;
ESTROGEN;
METOCLOPRAMIDE;
OLANZAPINE;
PLACEBO;
RISPERIDONE;
ZIPRASIDONE;
BRAIN DEPTH STIMULATION;
CELL DEATH;
CERVICAL DYSTONIA;
CERVICAL MYELOPATHY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DRUG INDUCED DISEASE;
DYSTONIA;
ESTROGEN THERAPY;
HUMAN;
NERVE CELL;
PARKINSON DISEASE;
PARKINSONISM;
PATHOLOGICAL GAMBLING;
BOTULINUM TOXINS;
CELL DEATH;
DEEP BRAIN STIMULATION;
DYSTONIA;
ESTROGEN REPLACEMENT THERAPY;
HUMANS;
PARKINSON DISEASE;
PARKINSONIAN DISORDERS;
|
EID: 33845921596
PISSN: 15452913
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (0)
|